HIV infection has a significant impact on the natural history of chronic hepatitis B virus (HBV)
infection, with increased levels of HBV DNA, accelerated progression of liver disease and …

Background: Estimates of the prevalence and disease burden of HIV/HCV coinfection in the
Asia Pacific Region are uncertain. Methods: A systematic review of indexed (PubMed …

Background Understanding demographic disparities in hospitalisation is crucial for the
identification of vulnerable populations, interventions, and resource planning. Methods Data …

Introduction Liver disease related to hepatitis B (HBV) and hepatitis C (HCV) may temper the
success of antiretroviral therapy (ART) in China. Limited data exist on their prevalence in …

We examined the impact of HBV/HIV coinfection on outcomes in hospitalized patients
compared to those with HBV or HIV monoinfection. Using the 2011 US Nationwide Inpatient …

Background The increasing number of HIV-patients and their complexity makes it necessary
to develop risk classification tools to improve the optimization of resources. Objective To …

Background. Human immunodeficiency virus (HIV) controllers have the striking ability to
maintain viremia at extremely low or undetectable levels without antiretroviral treatment …

Background Introduction of antiretroviral therapy (ART) has been associated with a decline
in human immunodeficiency virus (HIV)-related mortality, although HIV remains a leading …

Introduction: HIV controllers (HICs) experience relatively low-level viraemia and CD4
preservation without antiretroviral therapy (ART), but also immune activation that may …

Today, due to the increase in life expectancy in HIV-infected patients, the incidence of
related diseases such as hepatitis B and C due to similarity in transmission routes has …